Opyl Ltd
ASX:OPL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Opyl Ltd
Other Long-Term Assets
Opyl Ltd
Other Long-Term Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Opyl Ltd
ASX:OPL
|
Other Long-Term Assets
AU$6k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-11%
|
|
|
Iress Ltd
ASX:IRE
|
Other Long-Term Assets
AU$28.3m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
1%
|
|
|
WiseTech Global Ltd
ASX:WTC
|
Other Long-Term Assets
AU$45.7m
|
CAGR 3-Years
35%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
TechnologyOne Ltd
ASX:TNE
|
Other Long-Term Assets
AU$44m
|
CAGR 3-Years
28%
|
CAGR 5-Years
9%
|
CAGR 10-Years
20%
|
|
|
Linius Technologies Ltd
ASX:LNU
|
Other Long-Term Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Iris Energy Ltd
NASDAQ:IREN
|
Other Long-Term Assets
$33.4m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Opyl Ltd
Glance View
Opyl Ltd. is an information technology company. The company is headquartered in St Kilda, Victoria. The firm is focused on executing the change in direction into digital health, rebuilding the research and development pipeline to deliver solutions for the global health and life sciences sector. The firm has built a Opin, which is clinical trial recruitment platform that leverages social media, search engine optimization technologies and artificial intelligence science, matching patients directly to clinical trials. The firm is also developing Clinical trial prediction and protocol design tool. The firm subsidiaries include ShareRoot Inc, ShareRoot (Australian Ops) Pty Ltd, Opyl Services and Ludomade, Inc.
See Also
What is Opyl Ltd's Other Long-Term Assets?
Other Long-Term Assets
6k
AUD
Based on the financial report for Dec 31, 2024, Opyl Ltd's Other Long-Term Assets amounts to 6k AUD.
What is Opyl Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
-11%
